Literature DB >> 17943136

The emerging roles of forkhead box (Fox) proteins in cancer.

Stephen S Myatt1, Eric W-F Lam.   

Abstract

Forkhead box (Fox) proteins are a superfamily of evolutionarily conserved transcriptional regulators, which control a wide spectrum of biological processes. As a consequence, a loss or gain of Fox function can alter cell fate and promote tumorigenesis as well as cancer progression. Here we discuss the evidence that the deregulation of Fox family transcription factors has a crucial role in the development and progression of cancer, and evaluate the emerging role of Fox proteins as direct and indirect targets for therapeutic intervention, as well as biomarkers for predicting and monitoring treatment responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943136     DOI: 10.1038/nrc2223

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  486 in total

1.  Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.

Authors:  Lizhu Jiang; Xiaosong Wu; Peng Wang; Taoyu Wen; Chao Yu; Lei Wei; Hongyan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-13       Impact factor: 4.553

2.  FoxM1 mediates resistance to herceptin and paclitaxel.

Authors:  Janai R Carr; Hyun Jung Park; Zebin Wang; Megan M Kiefer; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 3.  Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Authors:  Tanya V Kalin; Vladimir Ustiyan; Vladimir V Kalinichenko
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

4.  FoxM1: a potential drug target for glioma.

Authors:  Yu Li; Sicong Zhang; Suyun Huang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 5.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest.

Authors:  Jean-Loup Duband
Journal:  Cell Adh Migr       Date:  2010-07-27       Impact factor: 3.405

7.  FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

Authors:  Xiaoming Zhu; Li Wei; Yangqiu Bai; Sen Wu; Shuangyin Han
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  Identification of a shared protective genetic susceptibility locus for colorectal cancer and gastric cancer.

Authors:  Na He; Lijun Liu; Xianglong Duan; Li Wang; Dongya Yuan; Tianbo Jin; Longli Kang
Journal:  Tumour Biol       Date:  2015-09-17

9.  β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.

Authors:  Jia Ma; Yanwei Lu; Sheng Zhang; Yan Li; Jing Huang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Li Liu; Kunyu Yang; Gang Wu; Shuangbing Xu
Journal:  Cell Death Differ       Date:  2018-02-02       Impact factor: 15.828

10.  Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.

Authors:  Jin Chen; Qin Huang; Feng Wang
Journal:  Tumour Biol       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.